Who Actually Writes Pre-Seed Cheques: Stage Appetite Across US, EU and UK Investor Theses

Only 50.6% of 542 profiled UK investors state explicit pre-seed appetite in their thesis — versus 79% who state seed appetite. That's a ~28-point gap, and it signals something founders routinely misread: the UK's pre-seed check-writer pool is structurally thinner than its seed pool. Seed capital is close to universal. Pre-seed capital is a coin-flip.

This matters because founders build outreach lists assuming "early-stage investor" is one homogenous category. It isn't. The data below, drawn from FMD's investor corpus, shows that stage appetite diverges sharply by round — and by region.

The stage-appetite gap founders keep misreading

Founders raising a first round often treat pre-seed and seed as adjacent, interchangeable targets. The thesis data says otherwise. Across every region in the corpus, seed appetite is stated far more often than pre-seed appetite. In the UK, the gap is nearly 30 points. That gap is not noise — it reflects real differences in fund structure, check size, and who is actually licensed and capitalized to write sub-$500K cheques versus $1M+ cheques.

Why 'early-stage' means something different in the US, EU and UK

"Early-stage" is a fund-marketing label, not a stage-appetite guarantee. A fund can call itself early-stage while only stating seed and Series A appetite in its actual published thesis. This is most visible in the UK, where a large share of nominally "early-stage" funds skip pre-seed entirely, leaving that check size to angels, accelerators, and a smaller set of dedicated micro-funds. In the US, by contrast, pre-seed and seed appetite run closer together, because the market has a deeper bench of dedicated pre-seed funds. In the EU, seed appetite is the highest of all three regions — a point covered in detail below.

Headline data — share of investors by stage and region (FMD corpus, n=1,588)

Here is the comparison table, pulled directly from stated thesis appetite fields across the corpus:

These are self-reported thesis appetite rates — the share of investors whose published thesis explicitly states they invest at that stage — not deal-flow counts or dollar volumes. That distinction matters. Crunchbase and Bain track dollars deployed and deal counts; FMD's corpus tracks what investors say they fund, which is the number founders actually need before sending a cold email.

UK pre-seed appetite: 50.6% of 542 profiled investors

Half of the UK's profiled investor base states pre-seed appetite. The other half doesn't — meaning a founder who blindly emails "every early-stage UK VC" is wasting outreach on roughly one in two names. Browse pre-seed and seed investors by stated stage appetite to filter this down before sending anything.

Seed appetite compared — US 86.4% vs UK 79% vs EU 90.8%

Seed appetite is close to universal everywhere, but not identical. EU investors state seed appetite at the highest rate (90.8%), US investors follow (86.4%), and UK investors trail both (79%). The 11.8-point gap between EU and UK seed appetite is smaller than the UK's own pre-seed-to-seed gap (28 points) — which tells you the bigger targeting risk for a UK founder isn't cross-border, it's within-region: picking the wrong UK list for the round size you're actually raising.

Why UK pre-seed appetite trails seed appetite by ~28 points

UK venture capital in 2024–2025 has been shaped by consolidation among institutional funds and a continued reliance on angel and accelerator capital to fill the earliest check sizes, per DWF's 2024–2025 UK VC review. BVCA-sourced data compiled by Burges Salmon shows UK institutional fund activity has increasingly concentrated at seed and Series A, where check sizes and ownership targets are large enough to justify fund economics at scale. That concentration is the structural reason pre-seed appetite lags: institutional funds with meaningful AUM are built to write seed-and-up checks, not the sub-£250K tickets that define UK pre-seed.

Angels, accelerators and micro-funds vs institutional seed capital

The 50.6% of UK investors stating pre-seed appetite skews toward angels, accelerator-affiliated funds, and a smaller cohort of dedicated micro-funds. Institutional seed and growth funds — the majority of the remaining 49.4% — simply don't write cheques small enough to qualify. This isn't a criticism of any individual fund's strategy; it's a market-structure observation. A £50M UK seed fund targeting 8–10% ownership at £2–4M rounds has no economic reason to write a £150K pre-seed cheque, and most don't claim to.

Why EU seed appetite (90.8%) outpaces both US and UK

EU seed appetite, at 90.8% of 174 profiled investors, is the highest of the three regions in this corpus. Macro data helps explain why: State of European Tech's startup investment trends chapter and Crunchbase's 2025 European funding report both point to European venture capital nudging higher through 2025, with early-stage activity — particularly AI-led seed rounds — driving a disproportionate share of new fund formation. When a market adds new early-stage fund managers faster than it adds new pre-seed-specific vehicles, seed appetite share rises relative to pre-seed. The EU sample size here (n=174) is smaller than the US or UK, so treat the 90.8% figure as directionally strong rather than as precise as the larger cohorts.

What this means for founder targeting strategy by geography

The practical takeaway: don't build one investor list and spray it across every stage. Build stage-specific lists per region.

• Raising pre-seed in the UK: treat the investor pool as roughly half the size of the seed pool. Filter aggressively for stated pre-seed appetite before outreach — don't rely on "early-stage" branding. View the UK pre-seed investor list to start from a pre-filtered set.
• Raising seed anywhere: appetite is near-universal (79–90.8%), so the constraint isn't finding investors who claim seed appetite — it's differentiating your round within a crowded, high-appetite pool.
• Comparing regions: if you're deciding between raising in the UK versus the EU at pre-seed, the EU and US corpora currently show fewer parsed pre-seed-specific data points at the same depth as UK — a gap that will close as the corpus grows, but worth noting now.

Match your round to the right investor list on Fit My Deck rather than assuming a single "early-stage" filter covers both stages.

Sequencing outreach — pre-seed-first vs seed-first investor lists

Sequencing outreach by stated appetite, not by fund brand, reduces wasted sends. A founder raising UK pre-seed should sequence: (1) dedicated pre-seed funds and angels with explicit pre-seed statements, (2) accelerators with pre-seed check components, (3) only then the smaller subset of seed funds that explicitly state pre-seed as a secondary appetite. Reversing that order — starting with brand-name seed funds — wastes the highest-leverage early outreach slots on investors statistically unlikely (49.4% of the time, per this corpus) to have pre-seed appetite at all.

For a deeper regional breakdown across all three markets, see the full US/EU/UK investor thesis benchmark series.

Methodology — how FMD parsed 1,800 investor theses for stage signals

This analysis is based on FMD's investor corpus, as of 2026-07-03, covering n=1,679 profiled investors across the US, UK, and EU. Each investor's published thesis — website, fund deck, or public statement — was parsed for an explicit stage-appetite field: does the thesis state pre-seed appetite, seed appetite, both, or neither? Named-investor claims in this piece are drawn only from that investor's own published thesis text, with the underlying source linked where cited. Percentages reported (UK pre-seed 50.6% of n=542; UK seed 79% of n=542; US seed 86.4% of n=872; EU seed 90.8% of n=174) reflect stated appetite, not confirmed deal activity — an investor can state appetite and still pass on most deals in that stage. Full detail on the parsing rules and stage-classification logic is available on the methodology page. For broader market context on deal volume and capital deployed — as distinct from stated appetite — see Crunchbase's 2025 global funding data and Bain & Company's Global Venture Capital Outlook.